Caribou Biosciences Ownership | Who Owns Caribou Biosciences?


OverviewForecastRevenueFinancialsChart

Caribou Biosciences Ownership Summary


Caribou Biosciences is owned by 43.54% institutional investors, 9.82% insiders, and 46.64% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of CRBU shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.84% of its assets in Caribou Biosciences shares.

CRBU Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCaribou Biosciences43.54%9.82%46.64%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.95M7.78%$11.39M
Vanguard group4.57M5.05%$7.26M
Pfizer4.69M5.04%$5.91M
Bank of america corp /de/4.16M4.66%$6.83M
Kynam capital management, lp3.07M3.30%$3.87M
Jpmorgan chase2.50M2.76%$3.97M
Schonfeld strategic advisors2.11M2.34%$3.36M
Geode capital management1.97M2.18%$3.14M
Blackrock funding, inc. /de1.88M2.02%$2.37M
Dimensional fund advisors lp1.73M1.92%$2.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
72 investment474.07K1.53%$753.77K
Pfizer4.69M1.03%$5.91M
Green alpha advisors425.68K0.51%$536.36K
Kynam capital management, lp3.07M0.42%$3.87M
Pfm health sciences, lp1.36M0.15%$1.71M
Milestone asset management409.56K0.11%$516.05K
Bruce250.00K0.10%$315.00K
Pale fire capital se775.05K0.10%$976.57K
Schonfeld strategic advisors2.11M0.02%$3.36M
Nelson capital management85.02K0.01%$107.13K

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/4.16M0.00%3.05M
Jpmorgan chase2.50M0.00%2.06M
Abrdn897.58K0.00%486.44K
Schonfeld strategic advisors2.11M0.02%467.74K
Two sigma advisers, lp1.47M0.01%416.60K

Top Sellers

HolderShares% AssetsChange
Avidity partners management lp---5.79M
Blackrock funding, inc. /de1.88M--4.46M
Alkeon capital management---2.74M
Paradigm biocapital advisors lp---2.17M
Pfm health sciences, lp1.36M0.15%-1.15M

New Positions

HolderShares% AssetsChangeValue
Ameriprise financial408.06K0.00%408.06K$648.81K
Wiley bros.-aintree capital336.56K0.00%336.56K$424.07K
Brevan howard capital management lp155.52K0.00%155.52K$195.96K
Y-intercept (hong kong)137.21K0.00%137.21K$172.89K
Hrt financial lp105.86K0.00%105.86K$133.00K

Sold Out

HolderChange
Nbc securities-2.00
Nelson, van denburg & campbell wealth management group-17.00
Frazier financial advisors-40.00
Rothschild investment-165.00
Daiwa securities group-176.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025132-0.75%40,507,235-19.40%431.48%6112.96%43-
Mar 31, 2025133-1.48%50,255,248-13.75%541.31%54-28.00%4462.96%
Dec 31, 20241332.31%58,115,66010.96%641.92%7321.67%27-15.63%
Sep 30, 2024130-6.47%52,373,357-1.44%571.64%61-8.96%33-19.51%
Jun 30, 2024139-10.32%53,138,330-20.38%591.04%67-8.22%41-6.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.64M2.84%-58.31K
ACATIS Datini Valueflex Fonds A2.00M2.15%-
Selectra J. Lamarck Biotech A1.50M1.61%-
Vanguard Institutional Extnd Mkt Idx Tr884.56K0.95%-346.95K
Fidelity Small Cap Index843.92K0.91%-
JPMorgan US Small Company L786.21K0.87%-22.84K
abrdn Life Sciences Investors793.50K0.85%-104.08K
iShares Russell 2000 Value ETF762.12K0.82%-
Candriam Global Equities Oncology625.00K0.69%-520.00K
iShares Biotechnology ETF556.11K0.61%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 14, 2025Haurwitz Rachel E. President and CEOBuy$20.40K
Feb 21, 2025MCCLUNG BARBARA G Chief Legal OfficerSell$4.81K
Feb 21, 2025Khan Ruhi Ahmad Chief Business OfficerSell$4.81K
Feb 21, 2025Kanner Steven Chief Scientific OfficerSell$4.81K
Jan 29, 2025Ryali Sriram Chief Financial OfficerBuy$24.65K

Insider Transactions Trends


DateBuySell
2025 Q113
2024 Q4--
2024 Q3--
2024 Q1--
2023 Q2--

CRBU Ownership FAQ


Who Owns Caribou Biosciences?

Caribou Biosciences shareholders are primarily institutional investors at 43.54%, followed by 9.82% insiders and 46.64% retail investors. The average institutional ownership in Caribou Biosciences's industry, Biotech Stocks , is 306.59%, which Caribou Biosciences falls below.

Who owns the most shares of Caribou Biosciences?

Caribou Biosciences’s largest shareholders are Blackrock (6.95M shares, 7.78%), Vanguard group (4.57M shares, 5.05%), and Pfizer (4.69M shares, 5.04%). Together, they hold 17.87% of Caribou Biosciences’s total shares outstanding.

Does Blackrock own Caribou Biosciences?

Yes, BlackRock owns 7.78% of Caribou Biosciences, totaling 6.95M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.39M$. In the last quarter, BlackRock decreased its holdings by -57.242K shares, a -0.82% change.

Who is Caribou Biosciences’s biggest shareholder by percentage of total assets invested?

72 investment is Caribou Biosciences’s biggest shareholder by percentage of total assets invested, with 1.53% of its assets in 474.07K Caribou Biosciences shares, valued at 753.77K$.

Who is the top mutual fund holder of Caribou Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Caribou Biosciences shares, with 2.84% of its total shares outstanding invested in 2.64M Caribou Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools